Ionis Pharmaceuticals: Q2 Earnings Snapshot
CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $85 million in its second quarter.
The Carlsbad, California-based company said it had a loss of 60 cents per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share.
The drug discovery and development company posted revenue of $188 million in the period, also exceeding Street forecasts. Eight analysts surveyed by Zacks expected $136.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS
